相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
A clear picture of renal cell carcinoma
A. Ari Hakimi et al.
NATURE GENETICS (2013)
Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle
Jin Kyeoung Kim et al.
BIOMATERIALS (2012)
AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery
Athulya Aravind et al.
BIOTECHNOLOGY AND BIOENGINEERING (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest
Zhiqiang Xu et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Zhe Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
RNA-binding protein nucleolin in disease
Kotb Abdelmohsen et al.
RNA BIOLOGY (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries
Sheila Fisher et al.
GENOME BIOLOGY (2011)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
Ara G. Hovanessian et al.
PLOS ONE (2010)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
FGFR2 Abnormalities Underlie a Spectrum of Bone, Skin, and Cancer Pathologies
Masaru Katoh
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells
Sridharan Soundararajan et al.
CANCER RESEARCH (2008)
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier et al.
LANCET (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides
XH Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
